Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept

Clinical Rheumatology

Volumn 28, Issue 8, 2009, Pages 1001-1003

  Carlsen, K M ^a   Riis, L ^a   Madsen, O R ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Etanercept; Infliximab; Methotrexate; Rheumatoid arthritis; Toxic hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AURANOFIN; ETANERCEPT; FOLIC ACID; HYDROXYCHLOROQUINE; INFLIXIMAB; LACTATE DEHYDROGENASE; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; COMBINATION CHEMOTHERAPY; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FIBROSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; RHEUMATOID ARTHRITIS; SIDE EFFECT; TOXIC HEPATITIS; TREATMENT DURATION;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67849084977     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1179-y     Document Type: Article

References (14)

1. Heiberg MS, Koldingsnes W, Mikkelsen K et al (2008) The comparative performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study. Arthrtis Rheum 59:234-240
2. Behm BW, Bickston SJ (2008) Tumor necrosis factor-alfa antibody for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 23:CD006893
3. Alonso-Ruiz A, Pijoan JI, Ansuategui E et al (2008) Tumor necrosis factor alpha drugs in rheumatois arthritis: Systematic review and metaanalysis of efficacy and safety. BMC Muskuloskelet Disord 9:52
4. Ostuni P, Botsios C, Punzi L et al (2003) Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 62:686-687
5. Wendling D, Auge B, Bettinger D et al (2005) Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy. Ann Rheum Dis 64:788-789
6. Germano V, Diamanti AP, Baccano G et al (2005) Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 64:1519-1520
7. Soto-Fernandez S, Gonzalez-Carro P, De Pedro-Esteban A et al (2006) Infliximab-induced hepatitis in a patient with Crohn's disease. Gastroenterol Hepatol 29:321-322
8. Wahie S, Alexandroff A, Reynolds NJ (2006) Hepatitis: A rare, but important, complication of infliximab therapy for psoriasis. Clin Exp Dermatol 31:460-461
9. Marques M, Magro F, Cardoso H et al (2007) Infliximab-induced lupus like syndrome associated with autoimmune hepatitis. Inflamm Bowel Dis 14:723-725
10. Hansen KE, Hildebrand JP, Genovese MC et al (2004) The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis. J Rheumatol 31(6):1098-1102
11. Thiéfin G, Morelet A, Heurgué A et al (2008) Infliximab-induced hepatitis: Absence of cross-toxicity with etanercept. Joint Bone Spine 75:737-739
12. García Aparicio AM, Rey JR, Sanz AH et al (2007) Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab. Clin Rheumatol 26:811-813
13. Feletar M, Brockbank JE, Schentag CT et al (2004) Treatment of refractory psoriatic arthritis with infliximab: A 12 month observational study of 16 patients. Ann Rheum Dis 63:156-161
14. Provenzano G (2004) Liver toxicity of infliximab in psoriatic arthritis. Ann Rheum Dis June 24: E-letter